Latest news

Filters (1)
May 11, 2005

Debiopharm announces marketing and supply agreement for Trelstar® in Canada

Read more
December 20, 2004

Debiopharm S.A. and Rowfarma S. de R.L. de C.V. enter into an Exclusive Licensing Agreement in Mexico for two approved…

Read more
September 29, 2004

Debiopharm and Watson Pharmaceuticals enter into an Exclusive Licensing Agreement for two approved urology products – Trelstar® DEPOT and Trelstar®…

Read more
March 23, 2004

Debiopharm´s Pamorelin Long Acting, Formulated Using Debio® PLGA Technology, receives Final Marketing Autorisation in Germany

Read more
December 2, 2003

Debiopharm S.A. seeks New Partner to Commercialise Trelstar® (Triptorelin Pamoate) in the US, Canada and Mexico for the Treatment of…

Read more
July 5, 2001

Swiss drug developer Debiopharm announces FDA approval of Trelstar TM LA for therapeutic use

Read more